Effect of Weekly or Successive Iron Supplementation on Erythropoietin Doses in Patients Receiving Hemodialysis

Publisher： Karger

E-ISSN： 2235-3186|89|1|110-112

ISSN： 1660-8151

Source： Nephron, Vol.89, Iss.1, 2001-08, pp. : 110-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Requiring Higher Doses of Erythropoietin Suggests Pregnancy in Hemodialysis Patients

By  

Nephron, Vol. 79, Iss. 4, 1998-07 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

Intravenous Low-Dose Iron Administration in Hemodialysis Patients Treated with Erythropoietin

By  

Nephron, Vol. 80, Iss. 3, 1998-11 ,pp. : 369-370

Karger

Access to resources Recommend Favorite

Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily

By  

American Journal of Nephrology, Vol. 19, Iss. 3, 1999-06 ,pp. : 405-410

Karger

Access to resources Recommend Favorite

Effect of L-Carnitine Supplementation in Hemodialysis Patients

By  

Nephron, Vol. 88, Iss. 3, 2001-06 ,pp. : 218-223

Karger

Access to resources Recommend Favorite

No Effect of Losartan on Response to Erythropoietin Therapy in Patients Undergoing Hemodialysis

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 538-539

Karger

Access to resources Recommend Favorite